Medical Condition News

RSS

TU Wien develops new remedy for celiac disease

Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.

24 Sep 2018

Gene therapy approach could help treat mitochondrial diseases

Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.

24 Sep 2018

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Kessler Foundation researchers have published their findings linking behavioral symptoms with employment outcomes among adults with moderate to severe traumatic brain injury.

24 Sep 2018

Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System

Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced positive clinical data from the company's recently expanded U.S. early feasibility study evaluating the safety of the investigational AccuCinch Ventricular Repair System designed for the treatment of heart failure and functional mitral regurgitation.

24 Sep 2018

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.

24 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

New virtual diabetes clinic may help manage condition of people with Type 2 diabetes

Blue Cross and Blue Shield of Georgia is taking an innovative approach to helping its consumers who have been diagnosed with Type 2 diabetes manage their condition to improve their health through a new virtual diabetes clinic with a smartphone app and monitoring tools.

24 Sep 2018

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies, today announced the U.S. Food and Drug Administration has lifted the partial clinical hold that had paused U.S.-based enrollment of new patients in its tazemetostat clinical trials.

24 Sep 2018

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

AstraZeneca today announced positive results from the Phase III DECLARE-TIMI 58 cardiovascular outcomes trial for FARXIGA, the broadest SGLT-2 inhibitor CVOT conducted to date.

24 Sep 2018

Genes predicting person's height may provide clues about causes of varicose veins

A person's height and certain genes that predict height are associated with varicose veins and may provide clues about what causes this condition and ways to prevent and treat it, according to new research in the American Heart Association's journal Circulation.

24 Sep 2018

‘Physicians of the mouth’? Dentists absorb the medical billing drill

On a recent Friday morning, more than 30 dentists and dental staffers gathered in a conference room to learn an arcane new skill: how to bill medical insurers.

24 Sep 2018

New study finds height as possible risk factor for developing varicose veins

The taller you are, the more likely you are to develop varicose veins, according to a study led by Stanford University School of Medicine researchers that examined the genes of more than 400,000 people in search of clues to what causes this common but little understood condition.

24 Sep 2018

MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'

The link between smoking and multiple sclerosis (MS) is “clearer than ever”, the MS Society has announced. Not only are people who smoke more likely to develop MS, smoking can also speed up how fast people with MS become disabled.

24 Sep 2018

New online, sound matching tool offers tinnitus sufferers potential treatment options

A tea kettle, buzzing cicada or screeching noise? Tinnitus suffers are being invited to use a new online, sound matching tool to help better understand their type of tinnitus and the potential treatments that might be able to help them.

24 Sep 2018

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long-term.

24 Sep 2018

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

24 Sep 2018

Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked

The number of people suffering from respiratory indications and the severity of those already suffering from the various diseases is expected to increase if air pollution in the UK goes unchecked, says GlobalData, a leading data and analytics company.

24 Sep 2018

Successful recovery from addiction means more than achieving abstinence

Successful recovery from drug and alcohol addiction through attending a residential treatment program means more to the person than just staying clean and sober, an Australian-first study has found.

24 Sep 2018

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.

24 Sep 2018

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD dementia.

24 Sep 2018

Medical Condition News

TU Wien develops new remedy for celiac disease

Gene therapy approach could help treat mitochondrial diseases

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

New virtual diabetes clinic may help manage condition of people with Type 2 diabetes

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

Genes predicting person's height may provide clues about causes of varicose veins

‘Physicians of the mouth’? Dentists absorb the medical billing drill

New study finds height as possible risk factor for developing varicose veins

MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'

New online, sound matching tool offers tinnitus sufferers potential treatment options

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked

Successful recovery from addiction means more than achieving abstinence

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News